NovoNordisk on Tuesday reported that its ... For comparison, Novo’s blockbuster Wegovy led to 15% weightloss in its pivotal Phase 3 trial lasting over a year.
Ozempic maker NovoNordisk on Wednesday said data showed its hotly anticipated weightloss pill prompts greater and more rapid weightloss than its blockbuster treatment Wegovy, amid ...